Biotech Clinical Trials

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Biotech Clinical Trials

Biotech Clinical Trials – Cohortias is the Clinical Research Organization

Latin America has emerged as a popular destination for biotech clinical trials in recent years.

The region offers a unique set of advantages, including a large and diverse patient population, experienced clinical research organizations, and favorable regulatory environments.

In this blog post, we will explore the biotech clinical trials landscape in Latin America and examine the reasons behind the region’s popularity among biotech companies.

Why Latin America is Attractive for Biotech Clinical Trials?

Large and Diverse Patient Populations:

Latin America has a population of over 600 million people, and its diversity is a major advantage for biotech clinical trials.

The region has a rich mix of ethnicities, races, and genetic backgrounds, which makes it easier for researchers to find suitable subjects for their studies.

Additionally, many countries in the region have large rural populations, which can be particularly useful for clinical trials focused on infectious diseases.

Experienced Clinical Research Organizations:

Latin America has a well-established network of clinical research organizations (CROs) that specialize in biotech clinical trials.

These CROs have experience working with biotech companies and can provide a range of services, including site selection, patient recruitment, and data management.

Additionally, many of these organizations have a strong understanding of the local regulatory environment, which can be a significant advantage for biotech companies.

Favorable Regulatory Environments:

Many countries in Latin America have streamlined their regulatory processes in recent years, making it easier for biotech companies to conduct clinical trials.

In many cases, the regulatory environment in Latin America is less complex and more efficient than in the United States or Europe.

Additionally, many countries in the region offer tax incentives and other financial benefits to biotech companies that conduct clinical trials in their countries.

Biotech Clinical Trials

Clinical Trials in Latin America: Challenges and Opportunities

While Latin America offers a range of advantages for biotech clinical trials, there are also some challenges that companies need to be aware of. One of the biggest challenges is the language barrier.

Many countries in the region speak Spanish or Portuguese, which can be a barrier for English-speaking researchers.

Additionally, cultural differences and local customs can sometimes create challenges for researchers.

Another challenge is the lack of infrastructure in some areas of the region. While many urban areas in Latin America have well-developed healthcare systems, rural areas often lack the infrastructure necessary to conduct clinical trials.

This can be a particular challenge for studies focused on infectious diseases, which often require access to remote populations.

Despite these challenges, Latin America remains an attractive destination for biotech companies looking to conduct clinical trials.

In fact, the region is expected to see significant growth in the biotech sector in the coming years. According to a report by, the Latin American biotech market is expected to grow at a CAGR of 10.44% between 2020 and 2025.


Biotech clinical trials in Latin America offer a range of advantages for companies looking to conduct clinical research.

The region’s large and diverse patient population, experienced clinical research organizations, and favorable regulatory environments make it an attractive destination for biotech companies.

While there are some challenges to conducting clinical trials in the region, these can be overcome with careful planning and preparation. As the biotech sector in Latin America continues to grow, we can expect to see more companies taking advantage of the region’s unique advantages for clinical research.

Biotech Clinical Trials

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Biotech Clinical Trials

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Biotech Clinical Trials

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Biotech Clinical Trials

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Biotech Clinical Trials

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Biotech Clinical Trials

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Biotech Clinical Trials

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Biotech Clinical Trials

The Cohortias Team

Biotech Clinical Trials

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Biotech Clinical Trials

Network & Partnerships